CD6
Basic information
Region (hg38): 11:60971680-61020377
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 48 | 48 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 48 | 1 | 0 |
Variants in CD6
This is a list of pathogenic ClinVar variants found in the CD6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-60971922-C-T | CD6-related disorder | Benign (Aug 20, 2019) | ||
11-61006589-C-A | not specified | Uncertain significance (Aug 30, 2022) | ||
11-61006628-A-T | not specified | Uncertain significance (Nov 21, 2023) | ||
11-61007670-C-A | not specified | Uncertain significance (Jun 06, 2023) | ||
11-61007673-G-A | not specified | Uncertain significance (Nov 25, 2024) | ||
11-61007755-C-G | not specified | Uncertain significance (Jul 05, 2023) | ||
11-61007757-C-G | not specified | Uncertain significance (Oct 12, 2024) | ||
11-61007779-C-T | not specified | Uncertain significance (Sep 03, 2024) | ||
11-61007802-C-G | not specified | Uncertain significance (Dec 18, 2023) | ||
11-61007829-A-T | not specified | Uncertain significance (May 23, 2024) | ||
11-61008546-T-G | not specified | Uncertain significance (Oct 03, 2023) | ||
11-61008560-G-C | not specified | Uncertain significance (Nov 22, 2023) | ||
11-61008592-G-A | not specified | Uncertain significance (Jun 30, 2024) | ||
11-61008631-T-C | CD6-related disorder | Benign (Nov 01, 2019) | ||
11-61008672-G-A | not specified | Uncertain significance (Dec 04, 2024) | ||
11-61008698-C-T | not specified | Uncertain significance (Jun 02, 2023) | ||
11-61008714-C-T | CD6-related disorder | Benign (Oct 22, 2019) | ||
11-61008737-C-T | CD6-related disorder | Benign (Oct 17, 2019) | ||
11-61008767-G-A | not specified | Uncertain significance (May 24, 2024) | ||
11-61008834-C-T | CD6-related disorder | Benign (Sep 24, 2019) | ||
11-61008835-G-C | CD6-related disorder | Benign (Nov 01, 2019) | ||
11-61009576-C-A | not specified | Uncertain significance (Dec 19, 2022) | ||
11-61009587-G-A | not specified | Uncertain significance (Nov 29, 2024) | ||
11-61009587-G-T | not specified | Uncertain significance (Apr 20, 2024) | ||
11-61009601-G-A | CD6-related disorder | Benign (Dec 03, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CD6 | protein_coding | protein_coding | ENST00000313421 | 13 | 48735 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000927 | 0.999 | 125717 | 0 | 31 | 125748 | 0.000123 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.91 | 253 | 354 | 0.715 | 0.0000196 | 4256 |
Missense in Polyphen | 69 | 123.43 | 0.55904 | 1525 | ||
Synonymous | 0.695 | 144 | 155 | 0.929 | 0.00000970 | 1344 |
Loss of Function | 3.00 | 12 | 29.6 | 0.405 | 0.00000135 | 349 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000363 | 0.000358 |
Ashkenazi Jewish | 0.000496 | 0.000496 |
East Asian | 0.000111 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000117 | 0.000114 |
Middle Eastern | 0.000111 | 0.000109 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Cell adhesion molecule that mediates cell-cell contacts and regulates T-cell responses via its interaction with ALCAM/CD166 (PubMed:15048703, PubMed:15294938, PubMed:16352806, PubMed:16914752, PubMed:24945728, PubMed:24584089). Contributes to signaling cascades triggered by activation of the TCR/CD3 complex (PubMed:24584089). Functions as costimulatory molecule; promotes T-cell activation and proliferation (PubMed:15294938, PubMed:16352806, PubMed:16914752). Contributes to the formation and maturation of the immunological synapse (PubMed:15294938, PubMed:16352806). Functions as calcium-dependent pattern receptor that binds and aggregates both Gram-positive and Gram-negative bacteria. Binds both lipopolysaccharide (LPS) from Gram-negative bacteria and lipoteichoic acid from Gram-positive bacteria (PubMed:17601777). LPS binding leads to the activation of signaling cascades and down-stream MAP kinases (PubMed:17601777). Mediates activation of the inflammatory response and the secretion of pro-inflammatory cytokines in response to LPS (PubMed:17601777). {ECO:0000269|PubMed:15048703, ECO:0000269|PubMed:15294938, ECO:0000269|PubMed:16352806, ECO:0000269|PubMed:16914752, ECO:0000269|PubMed:17601777, ECO:0000269|PubMed:24584089, ECO:0000269|PubMed:24945728}.;
- Pathway
- Cell adhesion molecules (CAMs) - Homo sapiens (human)
(Consensus)
Intolerance Scores
- loftool
- 0.584
- rvis_EVS
- 0.82
- rvis_percentile_EVS
- 88.02
Haploinsufficiency Scores
- pHI
- 0.242
- hipred
- Y
- hipred_score
- 0.542
- ghis
- 0.421
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.567
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Cd6
- Phenotype
- hematopoietic system phenotype; homeostasis/metabolism phenotype; immune system phenotype;
Gene ontology
- Biological process
- immunological synapse formation;adaptive immune response;acute inflammatory response to antigenic stimulus;receptor-mediated endocytosis;heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;lipopolysaccharide-mediated signaling pathway;response to lipopolysaccharide;positive regulation of T cell proliferation;innate immune response;positive regulation of cytokine production involved in inflammatory response
- Cellular component
- immunological synapse;extracellular region;integral component of plasma membrane;external side of plasma membrane;intrinsic component of plasma membrane;T cell receptor complex
- Molecular function
- lipopolysaccharide binding;scavenger receptor activity;protein binding;identical protein binding;lipoteichoic acid binding